{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:25:52Z","timestamp":1780525552978,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1124\/dmd.30.4.421","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T23:17:35Z","timestamp":1042672655000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes"],"prefix":"10.1016","volume":"30","author":[{"given":"Andrew A.","family":"Acheampong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Tang-Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.30.4.421_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3109\/00498259609167421","article-title":"Characterization of brimonidine metabolism with rabbit liver aldehyde oxidase.","volume":"26","author":"Acheampong","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.30.4.421_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-9556(25)06647-4","article-title":"Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.","volume":"23","author":"Acheampong","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.30.4.421_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0731-7085(95)01526-Q","article-title":"Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography\/mass spectrometric assay.","volume":"13","author":"Acheampong","year":"1995","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.30.4.421_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00002512-199812030-00005","article-title":"Brimonidine: a review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.","volume":"12","author":"Adkins","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1124\/dmd.30.4.421_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/112067219600600106","article-title":"Preclinical safety profile of brimonidine.","volume":"6","author":"Angelov","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"10.1124\/dmd.30.4.421_bib6","unstructured":"Burke J, Manlapaz C, Kharlamb A, Runde E, Padillo E, Spada C, Nieves A, Munk S, MacDonald T, Garst M, et al. (1996) Therapeutic use of \u03b12-adrenoceptor agonists in glaucoma \u03b12-Adrenergic Receptors: Structure, Function and Therapeutic Implications (Lanier S, Limbird L ed) pp 179\u2013187, Harwood Academic Publishers, Reading, UK."},{"key":"10.1124\/dmd.30.4.421_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.1985.1.309","article-title":"Corneal penetration and ocular bioavailability of drugs.","volume":"1","author":"Burstein","year":"1985","journal-title":"J Ocular Pharmacol"},{"key":"10.1124\/dmd.30.4.421_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/02713689008997579","article-title":"Corneal and conjunctival\/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.","volume":"9","author":"Chien","year":"1990","journal-title":"Current Eye Research"},{"key":"10.1124\/dmd.30.4.421_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1517\/13543784.7.7.1063","article-title":"Changing therapeutic paradigms in glaucoma management.","volume":"7","author":"David","year":"1998","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1124\/dmd.30.4.421_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(24)29683-X","article-title":"\u03b12-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.","volume":"296","author":"Donello","year":"2001","journal-title":"J Pharm Exp Ther"},{"key":"10.1124\/dmd.30.4.421_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000266875","article-title":"\u03b12-Adrenergic receptors in rat and rabbit eye: a tritium-sensitive film autoradiography.","volume":"21","author":"Elena","year":"1989","journal-title":"Ophthalmic Res"},{"key":"10.1124\/dmd.30.4.421_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jps.2600770103","article-title":"Mechanisms of corneal drug penetration I: in vivo and in vitro kinetics.","volume":"77","author":"Grass","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.30.4.421_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1099-0801(199902)13:1<86::AID-BMC816>3.0.CO;2-5","article-title":"Development of an HPLC method for determining the \u03b12-adrenergic receptor agonist brimonidine in blood serum and aqueous humor of the eye.","volume":"13","author":"Karamanos","year":"1999","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/dmd.30.4.421_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0161-6420(00)00654-0","article-title":"Vitreous concentrations of topically applied brimonidine tartrate.","volume":"10","author":"Kent","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1124\/dmd.30.4.421_bib15","unstructured":"Lai R, Hasson D, Chun T, Wheeler L (1997) Neuroprotective effect of ocular hypotensive agent brimonidine. XIth Congress of the European Society of Ophthalmology; June 1\u20135, Budapest; pp 439\u2013444, Monduzzi Editore, Bologna, Italy."},{"key":"10.1124\/dmd.30.4.421_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: recent developments and future challenges.","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocular Pharmacol"},{"key":"10.1124\/dmd.30.4.421_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000267170","article-title":"Localization of \u03b12-adrenergic receptors in the human eye.","volume":"24","author":"Matsuo","year":"1992","journal-title":"Ophthalmic Res"},{"key":"10.1124\/dmd.30.4.421_bib18","doi-asserted-by":"crossref","unstructured":"Maurice DM, Mishima S (1984) Ocular pharmacokinetics Pharmacology of the Eye (Sears ML ed) pp 19\u2013116, Springer-Verlag, Berlin.","DOI":"10.1007\/978-3-642-69222-2_2"},{"key":"10.1124\/dmd.30.4.421_bib19","unstructured":"National Institute of Health (NIH) (1985) Guide for the Care and Use of Laboratory Animals publication no. 86-23, NIH, Washington, DC."},{"issue":"Suppl","key":"10.1124\/dmd.30.4.421_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1755-3768.1985.tb06829.x","article-title":"The effect of ocular pigmentation on intraocular pressure response to timolol.","volume":"173","author":"Salminen","year":"1985","journal-title":"Acta Ophthalmol"},{"key":"10.1124\/dmd.30.4.421_bib21","doi-asserted-by":"crossref","unstructured":"Schoenwald RD (1993) Pharmacokinetics in ocular delivery Biopharmaceutics of Ocular Drug Delivery (Edman P ed) pp 159\u2013191, CRC Press, Boca Raton, FL.","DOI":"10.1201\/9780429284755-10"},{"key":"10.1124\/dmd.30.4.421_bib22","first-page":"1015","article-title":"The effect of melanin binding on brimonidine disposition in rabbit eyes.","volume":"33","author":"Tang-Liu","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/dmd.30.4.421_bib23","unstructured":"Tang-Liu D, Acheampong AA, Chien D-S, Usansky JI (1996) Pharmacokinetic and pharmacodynamic correlations for ophthalmic drugs Ocular Therapeutics and Drug Delivery: A Multi-Disciplinary Approach (Reddy IK ed) pp 122\u2013148, Technomic Publishing Company, London."},{"key":"10.1124\/dmd.30.4.421_bib24","first-page":"40","article-title":"Calculating the area of the curve and its standard error in single tissue sampling compartments.","volume":"9","author":"Tang-Liu","year":"1988","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.30.4.421_bib25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archopht.1995.01100120044006","article-title":"Effects of brimonidine on aqueous humor dynamics in human eyes.","volume":"113","author":"Toris","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 3","key":"10.1124\/dmd.30.4.421_bib26","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/S0039-6257(01)00206-5","article-title":"Role of \u03b12-adrenergic receptors in neuroprotection and glaucoma.","volume":"45","author":"Wheeler","year":"2001","journal-title":"Surv Ophthalmo"},{"issue":"Suppl 1","key":"10.1124\/dmd.30.4.421_bib27","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1177\/112067219900901S09","article-title":"From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.","volume":"9","author":"Wheeler","year":"1999","journal-title":"Eur J Ophthalmol"},{"key":"10.1124\/dmd.30.4.421_bib28","first-page":"65","article-title":"\u03b12-Adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.","volume":"40","author":"Yoles","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/dmd.30.4.421_bib29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1023\/A:1015997823755","article-title":"Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses.","volume":"7","author":"Zane","year":"1990","journal-title":"Pharm Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624044167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624044167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.30.4.421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:15:28Z","timestamp":1739902528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624044167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0090955624044167"],"URL":"https:\/\/doi.org\/10.1124\/dmd.30.4.421","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.30.4.421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}